Omnium Global’s vision is to de-risk products commercialization to maximize impact on global health. Most Life Science startups fail before reaching approvals & having an impact on patients. Omnium helps companies beat these odds by reducing risks, timelines, & costs associated with product commercialization. We do this by working side by side at critical growth points focused on driving immediate results in both commercial and scientific operations.
Our track record reflects our expertise, with successful launches of diverse biopharmaceuticals spanning recombinant proteins, vaccines, cell/gene/oncolytic virus therapies, impacting over 20 countries. We boast >50 approved INDs, 150+ publications & invited conference presentations, and over $750m in commercial agreements closed.

We Support:

Life Sciences Companies: Optimize Marketing & Commercialization Strategy
Biotech Companies: Decrease Risk, Costs, & Time to Market
CDMOs: Implement Robust Processes, Improve Execution, Increase Profitability
Investors: Make Informed Investments & Improve Returns

Commercial Operations:

Strategy & Corporate Development: Executing your vision, strategizing marketing, fundraising, product launches, exit strategies
Marketing & Communications: Market intelligence, branding, thought leadership, content development
Business Development: Identifying targets, lead engagement, proposal generation
Business Operations: Portfolio strategy, capacity management, metrics development, program management

Scientific Operations:
Process & Analytical Development: Product development, scale-up, commercialization
Quality, CMC, & Outsourcing: Ensuring compliance, CDMO sourcing, due diligence, service provider management, RFP creation
Programs Management: Project planning, risk mitigation, meeting timelines, stakeholder coordination, supply chain management
Facility Design & Procurement: Engineering design, equipment sizing, gap analysis, commercial negotiations, facility auditing